About
Augma Biomaterials is dedicated to the development, production, and marketing of synthetic bone substitutes for the dental market. The companys 3D Bond (biphasic calcium sulfate) functions as a scaffold for bone regeneration in dental procedures and is intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region. Augmas Bond Apatite combines 3D Bond with a formula of hydroxyapatite granules to create a cement-based osteoconductive composite. Bond Apatite is a synthetic bone substitute used for bone reconstruction in a range of dental applications and is intended for filling, augmenting, and reconstructing a wide variety of defects in the maxillofacial bones. The product is FDA cleared and CE approved.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Augma Biomaterials' primary focus?
- Augma Biomaterials is dedicated to the development, production, and marketing of synthetic bone substitutes for the dental market.
- What is Augma Biomaterials' flagship product for bone regeneration?
- Augma Biomaterials' 3D Bond, a biphasic calcium sulfate, functions as a scaffold for bone regeneration in dental procedures, intended to fill, augment, or reconstruct bony defects in the oral and maxillofacial region.
- What is Bond Apatite and its purpose?
- Bond Apatite from Augma Biomaterials combines 3D Bond with hydroxyapatite granules to create a cement-based osteoconductive composite. It is a synthetic bone substitute for bone reconstruction in various dental applications, including filling, augmenting, and reconstructing maxillofacial bone defects.
- Are Augma Biomaterials' products approved by regulatory bodies?
- Yes, Augma Biomaterials' Bond Apatite product is FDA cleared and CE approved.
- When was Augma Biomaterials founded?
- Augma Biomaterials was founded in November 2009.
- Where is Augma Biomaterials headquartered?
- Augma Biomaterials is headquartered in Caesarea, Israel.
- Does Augma Biomaterials have an office outside of Israel?
- Yes, Augma Biomaterials has an office in Monroe Township, New Jersey, USA.
- In which geographic markets does Augma Biomaterials operate?
- Augma Biomaterials operates in geographic markets including Germany, United Kingdom, Israel, France, Romania, South Africa, Hungary, Sweden, Turkey, Poland, and the United States, with a global presence.
- What was a notable recognition for Augma Biomaterials' technology in January 2019?
- In January 2019, the inventor of Augma Biomaterials' dental material technology that regrows bone was named an Edison Awards Finalist.